Counterfeiters lurk in free trade zones

Counterfeit drugmakers have found some unlikely allies: free trade zones. Set up by governments to promote trade, these zones have little regulatory oversight, and tariffs are waived. So it's relatively simple for counterfeiters to disguise the source of a drug, or to make and sell tainted products, according to a new investigation by the New York Times.

Recently, a stash of fake drugs was seized in a free trade zone in Dubai; the meds were destined for Americans who believed they were buying drugs from Canada, via an Internet pharmacy. It's a typical case of counterfeiters using one or more free trade zones to avoid detection.

Counterfeiting, of course, is a big threat to Big Pharma, because most of the fake drugs are tainted knockoffs of big-time brand name meds. And for patients, the fakes can be deadly.

- read the article from the New York Times

Related Articles:
Counterfeit drugs plaguing Big Pharma. Report
Chinese pharma recalls counterfeit drug. Report
FDA can't guarantee drug safety. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.